Safety board recommends continuation of Alimera/pSivida trial
Medidur is a tiny, injectable device being studied as a way to deliver fluocinolone acetonide, a corticosteroid, to the retina for up to three years as a treatment
Medidur is a tiny, injectable device being studied as a way to deliver fluocinolone acetonide, a corticosteroid, to the retina for up to three years as a treatment
Adventrx plans to further investigate Thiovir efficacy against multiple H5N1 strains of avian influenza in both in vitro and in vivo studies in collaboration. “We are encouraged by
The deal includes Neuromed’s lead compound, NMED-160, which is currently in phase II development for the treatment of pain. Under the terms of the agreement, Neuromed will grant
PTC’s small molecules are designed to inhibit the hepatitis C virus (HCV) internal ribosome entry site (IRES) mediated production of viral proteins. The IRES is highly conserved among
Based on the previous performance of Altropane and Boston’s monitoring of non-blinded data from the approximately 200 patients enrolled in the current trial, the company believes it may
The trial is an open-label, multi-center study designed to examine the safety and efficacy of SNS-595 as a second-line agent in patients with small cell lung cancer who
Patients completing the 24-week Canadian phase III trial, named SPIRIT, were given the opportunity to continue therapy for an additional 36 weeks or to discontinue therapy. Those patients
The primary purpose of the upcoming study is to confirm positive clinical results published in 2002, which demonstrated that Celadrin oral capsules improved range of motion and overall
In a letter to National Institute of Environmental Health Sciences (NIEHS) director Dr David Schwartz, eight Congressional and Senate leaders stated that any relevant studies conducted by the
The key product to be acquired is levofolinic acid (LFA), the pure active isomer of calcium leucovorin, a component of cancer standard of care treatment 5-fluorouracil (5-FU) containing